This overlap highlights potential early molecular footprints of AD pathophysiology present even in asymptomatic APOE ε4 carriers and underscores the utility of contextualizing by APOE genotype when seeking AD-relevant proteomic signals. The gene discussed is APOE; the disease is Alzheimer disease.